Status:
COMPLETED
Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients
Lead Sponsor:
Alberta Health services
Conditions:
Colon Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study will determine whether a new diagnostic test called the Cell Search Assay can detect circulating colon cancer cells in patients who have had surgery for colon cancer and had visible cancer ...
Eligibility Criteria
Inclusion
- stage II or III colon cancer
Exclusion
- none
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00351572
Start Date
July 1 2006
Last Update
April 18 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2